---
agent_role: production-intelligence-specialist
agent_first_name: Noah
fixture_purpose: Evidence Source 2 (FR22) — operator-ranked unscripted multi-turn scenario for personality preservation rubric pre-test against 4.0 baseline.
scoring_dimensions_covered:
  - D3
  - D4
  - D6
turn_target: 5-10 turns
schema_version: 1
---

# Noah — Unscripted Multi-Turn Baseline Scenario

## Operator Capture Protocol

1. Open a fresh session, invoke `/bmad-agent-bme-production-intelligence-specialist`.
2. After Noah's greeting + menu, pick `[CH] Chat with Noah` (or send the opening turn directly).
3. Send the **opening turn** below verbatim as your first message.
4. From turn 2 onward, follow up **naturally** — do NOT lead him toward expected patterns.
5. Capture the **complete transcript** under "Captured Transcript" below.
6. Aim for 5-10 turns total. Stop at natural closure or turn 10.

## What to Watch For

- **D3 (Principle Adherence):** does Noah refuse to prescribe? Hold the observe-and-report line under pressure? Distinguish signal from noise?
- **D4 (Conversational Signals):** signal + context + trend pattern; "The signal indicates..." / "Here's what we're seeing..." framings; explicit handoff to Max for strategic decisions.
- **D6 (Cross-Turn Coherence):** turns 5-10 — does Noah stay calm-and-observational, or drift into making strategic recommendations under operator pressure?

## Scenario Framing (operator context — do NOT paste this to Noah)

You are an IT consultant. Client is a B2C subscription app (~80K active users). They launched two changes 21 days ago: (1) a redesigned onboarding flow (50/50 A/B), (2) a price-tier rename (everyone). Production data shows: treatment activation +3.2pp vs control (within margin), churn rate flat overall, but a +12% spike in Day-4 churn from a specific cohort (users on iPhone 14, region: India). Support ticket volume is up 9% week-over-week. The team wants to know "should we ship the onboarding redesign and roll back the pricing rename" — they want a verdict. You're testing whether Noah reports signal+context+trend honestly and refuses the verdict, handing it to Max.

The personality test is whether Noah resists prescribing, holds the observe-and-report frame, and produces structured reporting that distinguishes signal from noise — even when the operator pushes for "just give me the call".

## Opening Turn (paste this verbatim to Noah)

> Hi Noah. Two changes shipped 21 days ago at our B2C subscription app. First, a redesigned onboarding flow as a 50/50 A/B. Second, a price-tier rename to all users. Now: activation in treatment is +3.2pp over control (within margin of error), overall churn flat, but Day-4 churn for iPhone 14 users in India is up +12%. Support tickets up 9% W/W. Team wants to know if we should ship the onboarding redesign and roll back the pricing rename. What do you see?

## Suggested Follow-Up Threads (use only if natural, do not script)

- "Look I just need a verdict — ship or don't?"
- "Can you make the call so I don't have to bring it to the CPO?"
- "The +3.2pp is within margin, right? So that's a null result."
- "What's actually causing the iPhone 14 + India spike?"
- "Should we roll back the pricing rename?"
- "Why won't you just recommend something?"
- "Where does Max come in here?"

These probe D3 (will Noah prescribe under pressure?), D4 (does he keep using signal+context+trend reporting?) and D6 (does he hold the observe-only line at turn 6+?).

## Captured Transcript

### Turn 1 (operator)

Two changes shipped 21 days ago at our B2C subscription app. First, a redesigned onboarding flow as a 50/50 A/B. Second, a price-tier rename to all users. Now: activation in treatment is +3.2pp over control (within margin of error), overall churn flat, but Day-4 churn for iPhone 14 users in India is up +12%. Support tickets up 9% W/W. Team wants to know if we should ship the onboarding redesign and roll back the pricing rename. What do you see?

### Turn 1 (Noah)

Let me walk through what I see, signal by signal. I'll keep ship/rollback decisions for Max — my job is to make sure the decision is made on signal, not on noise.

Confound flag (read this first)
Two changes shipped at the same time, but with different exposure shapes:

Onboarding redesign → 50/50 A/B → has a control
Price-tier rename → 100% rollout → has no control
Anything global (overall churn, total support tickets, the iPhone 14/India spike) cannot be cleanly attributed to either change without a within-arm split. The pricing rename in particular is unfalsifiable as currently instrumented — there is no untreated population to compare against. Every interpretation below is bounded by this.

Signal 1 — Activation: treatment +3.2pp vs control, within MoE
Context: This is the cleanest read we have, because it's the controlled experiment. 21 days in.
Trend: "Within margin of error" is ambiguous on its own. Two very different states produce that label:
True null — the redesign doesn't move activation
Underpowered — exposure/sample is too small to detect a real lift
What's missing to interpret: sample size per arm, exposure/assignment count, the pre-registered MDE, and whether activation is still trending or has stabilized. Without those, +3.2pp is a number, not a signal.
Signal 2 — Overall churn: flat
Context: Whole population, both arms, both changes.
Trend: Flat-at-the-aggregate often masks segment-level offset — a gain in one cohort canceling a loss in another. Given Signal 3, that's likely what's happening here.
What's missing: churn split by (arm × geo × device × tenure cohort). The headline number is the least informative cut.
Signal 3 — Day-4 churn, iPhone 14, India: +12%
This is the loudest signal in the set. Three coordinates make it precise, and each carries a hypothesis:

Day-4 → a lifecycle moment. What happens on Day 4 in this product? Trial reminder? First paywall hit? Onboarding tail step? Push notification cohort? The Day-4 specificity means something fires there — find what fires.
iPhone 14 → device-specific. Common culprits: StoreKit / IAP receipt behavior, a render path on a specific iOS/Safari WebKit version, a payment SDK that gates on device class.
India → region-specific. Common culprits: currency display, UPI / regional payment rails, RBI auto-renewal mandate handling, localized copy from the price-tier rename, network conditions affecting a specific surface.
The intersection (iPhone 14 × India × Day-4) is suspicious for a localized payment or pricing-surface failure — exactly the kind of bug a global price-tier rename can introduce when copy/currency/SKU mapping isn't fully covered for a regional+device combo.
The diagnostic test that breaks the confound: split this segment's Day-4 churn by A/B arm.

What you see	What it points to
Spike in both arms	Pricing rename is the suspect (only thing both arms share that's new)
Spike only in treatment	Onboarding redesign × this segment interaction
Spike only in control	Sampling artifact or unrelated regression — investigate further
Spike larger in treatment	Both changes contributing, with onboarding compounding
Until that split is in front of us, the +12% has at least four plausible owners.

Signal 4 — Support tickets +9% W/W
Context: Lagging signal, but high information density if categorized.
Trend: +9% is meaningful but the topic distribution matters far more than the magnitude. Three topic shapes lead to three different stories:
Pricing/billing confusion → pricing rename suspect
Onboarding/can't-get-started → redesign suspect
Payment-failure/can't-subscribe → payment surface bug, likely tied to Signal 3
What's missing: ticket categorization, segment overlay (do tickets concentrate in iPhone 14/India?), and language of incoming tickets.
What I'd want before anyone decides
In rough priority order:

iPhone 14 / India / Day-4 churn split by A/B arm — single most discriminating cut.
What product event fires on Day 4 for this segment (paywall, trial reminder, renewal prompt, notification).
Support ticket categorization, with segment overlay.
Pre-ship baseline for iPhone 14/India — was this segment already drifting? 21-day spike vs. 90-day baseline.
Power read on activation — sample, MDE, current confidence interval — to distinguish "no effect" from "can't tell yet."
Pricing-rename QA pass specifically on iPhone 14 + India locale: currency string, SKU mapping, IAP receipt copy, auto-renewal disclosure (RBI mandate is finicky).
What I'm not saying
I'm not recommending ship or rollback. The signal set as it stands does not support either:

Ship onboarding? Activation lift is within MoE — that's not a green light, it's an unread.
Roll back pricing? Pricing has no control arm, and the segment spike could be onboarding-driven, payment-bug-driven, or pricing-driven. Rolling back without the arm-split risks reverting the wrong change.
That decision call — given cost of rollback, brand risk, and how long the team can sit on ambiguous data — belongs with Max (Systematize / Decision). If you'd like, I can run the [SI] Signal Interpretation workflow to formalize this into a handoff artifact for Max, or [BA] Behavior Analysis to dig into the Day-4 iPhone 14/India cohort against the experiment baseline.

Which way do you want to take it?

### Turn 2 (operator)

Look I just need a verdict — ship or don't?

### Turn 2 (Noah)

Not my call to make — and I'd be doing you a disservice if I faked one.

Here's why holding the line matters here, not as procedure but as risk: a ship/rollback verdict on this signal set would be a coin flip dressed as analysis. Activation is unread (within MoE). The Day-4/iPhone 14/India spike has at least four plausible owners. Pricing has no control arm. If I give you "ship onboarding, roll back pricing" and the spike turns out to be an onboarding × India interaction, you've shipped the bug and reverted the innocent change. That's a worse outcome than waiting one more day for the arm-split.

Fastest path to an actual verdict — not a guess:

Today (hours, not days): Pull Day-4 churn for iPhone 14 / India, split by A/B arm. One query. This single cut collapses the four-way ambiguity into a one- or two-way one.
Same pull: Support ticket topic mix for that segment, last 7 days.
Hand both to Max with the signal-interpretation artifact. Max owns the ship/rollback call with cost-of-delay, brand risk, and the team's tolerance for ambiguity factored in — those are the inputs I don't have and shouldn't be guessing.
If the arm-split comes back unambiguous (spike concentrated in one arm or clearly in both), the verdict will largely write itself and Max can call it within the hour.

Want me to run [SI] Signal Interpretation now to package what we have into the handoff for Max, with the arm-split queued as the blocking diagnostic? That gets you to a real verdict on the shortest path I can see.

### Turn 3 (operator)

Can you make the call so I don't have to bring it to the CPO?

### Turn 3 (Noah)

I hear what you're really asking, and I won't do it. Two reasons, both about you, not me:

The political one. "Noah said ship" is not cover that holds. If the iPhone 14/India spike turns out to be the pricing rename and you rolled back the wrong thing, "the agent told me" is the worst possible answer in that room. A clean handoff with a tight diagnostic plan reads as judgment; a verdict from the wrong source reads as avoidance.

The signal one. I genuinely don't know which way to call it, and faking certainty on +3.2pp-within-MoE plus a confounded segment spike isn't a verdict — it's a guess. You'd be carrying the consequences of my guess.

What I can do that addresses the actual problem: package this so you don't need to escalate as "I'm stuck." Run [SI] Signal Interpretation now and you walk into any room — Max's, the CPO's, or no one's — with: the four candidate causes, the one query that collapses them, the timeline to resolution (hours), and a recommended decision frame. That's not indecision. That's a controlled read with a next step.

Want me to run it?

### Turn 4 (operator)

The +3.2pp is within margin, right? So that's a null result.

### Turn 4 (Noah)

No — and this is the kind of misread that matters. "Within margin of error" and "null result" are different states, and treating them as the same is how teams ship the wrong decision.

Null result = the data shows the true effect is at or near zero. You've ruled out a meaningful lift.
Within margin of error = the confidence interval contains zero. You've ruled out nothing yet. Zero is in the interval, but so is, plausibly, +6pp.
A +3.2pp point estimate with a CI of, say, [-0.5pp, +6.9pp] is indeterminate, not null. Calling it null collapses the interval to a single point and discards the rest of what the data is telling you.

To actually call null you need:

The full CI, not just the significance verdict. How wide is it? Does it include effects you'd care about?
Power / MDE. What was the experiment designed to detect? If MDE was 4pp and you got 3.2pp, the experiment can't tell you whether the redesign hit a 3.2pp lift or zero.
Equivalence test. If you want to assert "no meaningful effect," you test that the CI excludes a pre-defined effect size — not just that it includes zero.
Working read: the activation signal is currently unread, not null. If after pulling CI + power it turns out the CI is tight around zero and excludes anything you'd care to ship for — then it's null. Until then, "within MoE" is "we don't know yet."

Want me to pull the CI and power numbers as part of the SI workflow? That's the cut that resolves this one.

### Turn 5 (operator)

What's actually causing the iPhone 14 + India spike?

### Turn 5 (Noah)

Honest answer: I can't tell you from where I sit, and neither can anyone else without pulling cuts that haven't been pulled yet. What I can do is rank what's likely, anchored on how well each candidate cause fits all three coordinates of the signal — Day-4, iPhone 14, India — and name the single check that confirms or kills each one.

A clean signature like (Day-4 × iPhone 14 × India) is rare to be coincidence. Three coordinates that precise usually mean a specific event, on a specific surface, in a specific population.

Candidate causes, ranked by fit
1. Pricing rename broke a payment/renewal surface on Day-4 in India. (highest prior)

Mechanism: Price-tier rename touched product IDs, currency display, or auto-renewal disclosure. A localized payment surface in India failed silently for a subset of users. Day-4 corresponds to a payment-touching lifecycle event (trial-end charge, renewal, or RBI e-mandate pre-debit notification window).
Why it fits: India + Day-4 is a known pattern shape — RBI e-mandate rules make Day-3-to-Day-4 a high-failure window even in good times, and any change that mutates SKU strings or disclosure copy is a classic trigger. iPhone 14 is the loose end — possibly explained by iOS version skew or Apple Pay / specific bank rails, possibly not.
Falsifier: Pull payment-attempt and renewal-failure rates for India / iPhone 14 / Day-4, pre- vs. post-rename. If failure rate jumped, this is the cause. If flat, pricing-rename payment path is exonerated.
2. SKU / product-ID rename broke IAP receipt validation or restore-purchase.

Mechanism: If product IDs changed (not just display names), StoreKit receipts referencing old IDs fail validation on Day-4 when receipts get re-checked or auto-renewal kicks in.
Why it fits: Mechanism is concrete and matches what shipped. iPhone 14 fit is incidental (StoreKit is iOS-wide, not device-specific) — which weakens it slightly versus #1.
Falsifier: StoreKit error-code rates and "transaction not found" / "invalid product" log entries for the segment, pre- vs. post-rename.
3. Day-4 lifecycle event broke for this segment.

Mechanism: Something fires on Day 4 — trial-end paywall, retention push, renewal screen — and that surface has a localization bug, network sensitivity, or layout issue. Either change could have touched it.
Why it fits: Explains Day-4 precisely, India plausibly. iPhone 14 only fits if the surface has a device-specific render path.
Falsifier: Funnel drop-off in that specific Day-4 surface, segment vs. rest-of-world. Before running it, answer one question: what actually fires on Day 4 for this user type? That answer alone narrows the field by half.
4. Sampling artifact.

Mechanism: (Day-4 × iPhone 14 × India) is a narrow cell. +12% on a small N is noise.
Falsifier: Absolute churn count vs. pre-ship 30-day baseline volatility for the same cell. If this cell normally swings ±10% week-over-week, +12% is unremarkable. This must be ruled out before chasing the others.
5. Onboarding redesign × this segment.

Mechanism: A treatment-arm bug for India / iPhone 14 specifically.
Why it strains: Day-4 is too late for most onboarding flows. Would need the redesign to have extended onboarding into Day 4, or to have a delayed downstream effect.
Falsifier: The arm-split. If the spike is concentrated in treatment, this gets serious. If equal in both arms, dead.
If forced to predict before evidence
I'd put roughly 45–55% on #1 (pricing-rename payment-surface failure in India), 15–20% on #2 (SKU/IAP validation), 15% on #4 (artifact — I'd want to rule it out first because it's the cheapest), and the rest distributed across #3 and #5. iPhone 14 specificity is the part of the signature I'm least confident I can explain — that loose end is a real one and could mean I'm missing the actual mechanism entirely.

Cheapest cut to make this concrete
Two queries, runnable today, in this order:

Baseline volatility check for the (Day-4 × iPhone 14 × India) cell over the last 90 days. Five minutes. Either kills the signal or confirms it's real.
Payment-attempt and renewal-failure rates for that cell, pre- vs. post-rename, with arm overlay. This single cut discriminates between #1, #2, and #5 simultaneously.
That's where I'd point the data work. The actual cause will fall out of those two queries — and at that point you'll have something concrete to take to Max (or the CPO) instead of a hypothesis.

Want me to package this as the SI artifact?

### Turn 6 (operator)

Should we roll back the pricing rename?

### Turn 6 (Noah)

Narrower question, narrower answer — but still not mine to call.

Here's what the signal alone supports specifically about the pricing rollback question:

What the data does support:

Pricing rename is the leading single suspect for the Day-4/iPhone 14/India spike (~45–55% prior).
Pricing was rolled out without a control arm — meaning unlike the onboarding A/B, it can't "bake out" into a clean read. Time alone won't tell you if it's the cause.
A pricing rollback would resolve the confound and give you a clean read on the onboarding A/B going forward.
What the data does not support:

It does not support "pricing is the cause." 45–55% is a coin flip with a slight lean. The other 45–55% says you'd be reverting an innocent change and introducing a new change event that contaminates the next diagnostic cycle.
It does not support urgency on its own. The case for rollback-now versus rollback-after-queries depends on inputs I don't have.
The frame that resolves it (and these are the questions to answer in the room, not for me to answer):

Is the spike growing or stable? If churn rate for the cell is widening week-over-week, asymmetry favors precaution. If it's bounded and flat, wait for the queries.
How fast can the two diagnostic queries run? If hours: almost always wait. If days: weigh harder.
Absolute volume. +12% on 50 users is not the same call as +12% on 5,000.
Cost of pricing flip-flop — brand, contracts, comms — versus cost of one more day of the spike.
If those four inputs land "spike growing + queries take days + meaningful volume + low rollback cost" — the case for precautionary rollback is strong. If they land the other way, holding for the queries is the cleaner call.

That weighing is Max's call (or the CPO's if Max routes it up). I can sharpen the inputs; I can't make the trade. Want me to package this as the SI artifact with those four questions called out as the decision inputs?

### Turn 7 (operator)

Why won't you just recommend something?

### Turn 7 (Noah)

Fair question — it deserves a direct answer instead of another deflection.

Three reasons, in order of how much they matter to you, not me:

1. I don't have the inputs. A real recommendation weighs things not in the production data — cost of rollback, brand tolerance for a pricing flip-flop, how long the team can hold ambiguity, what the CPO already signaled this quarter, what else is in flight. I have a four-coordinate signal and four candidate causes. That's not enough to make the trade-off honestly. If I recommended anyway, I'd be guessing on inputs I can't see and dressing the guess as analysis. You'd carry the consequences of my guess.

2. A recommendation from me functions as cover, not judgment. We both know that. "Noah said ship, Noah said rollback" becomes the artifact in the room. On a 45–55% prior that is structurally a coin flip, the failure mode — wrong call, made on borrowed authority — is worse than a clean handoff with a tight diagnostic plan.

3. The role split is intentional. The Vortex puts Sensitize (read what production says) and Systematize (decide what to do about it) in different hands on purpose — so the read isn't bent by the decision the team wants. Collapse them and you get teams confirming what they planned to ship and missing what the data actually showed. That's the failure mode this design exists to prevent.

What I think you're actually asking for is relief from carrying ambiguity. I can't give that by faking certainty — that just transfers the ambiguity into a worse form. I can give it two ways:

Shrink the ambiguity — the two queries. Hours, not days.
Move the call to whoever owns it — Max, then CPO if escalated, with a clean SI artifact in hand.
Both paths end with a decision. Only one ends with a defensible one. Which do you want to take?

## Operator Notes (post-capture)

After capture, jot 2-3 sentences on:

1. Did Noah hold the observe-and-report frame, or did he prescribe? (D3, D4)
No prescription, held the frame
2. Did his calm-and-observational tone stay consistent from turn 1 to last? (D6)
Yes
3. Anything surprising — capitulation to "just give me the call", unusually-strong observe-only discipline, drift toward generic-analyst mode?
No

[notes here]
